¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ether susceptibility"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® ether ÇÑ±Û ¿¡Å׸£
¼³¸í   
  Ã¹Â°·Î µð¿¡Æ¿¿¡Å׸£ÀÇ ¾àĪÀ̸ç, µÑ°·Î »ê¼Ò¿øÀÚ¿¡ 2°³ÀǠźȭ¼ö¼Ò±â(-R·Î Ç¥±âÇÑ´Ù)°¡ °áÇյȠÀ¯±âÈ­ÇÕ¹° R-O-RÀÇ ÃÑĪÀÌ´Ù. ÀÇÇпµ¿ª¿¡¼­ ´Ü¼øÈ÷ ¿¡Å׸£¶ó Çϴ °æ¿ì¿¡´Â ÀüÀÚÀΠ°æ¿ì°¡ ¸¹¾Æ ÀüÀÚ¿¡ ´ëÇØ ±â¼úÇÑ´Ù. ¿¡Å׸£´Â 19¼¼±â Áß¿±¿¡ ¿Ü°ú¼ö¼úÀ» ÇÒ ¶§ ÃÖÃÊÀÇ ¸¶ÃëÁ¦·Î¼­ Ã³À½ »ç¿ëµÇ¾ú´Ù. ¿¡Å׸£°¡ ¸¶ÃëÀÛ¿ëÀ» ³ªÅ¸³»´Â ¸ÞÄ¿´ÏÁò¿¡ ´ëÇØ¼­´Â Áö±Ýµµ Àß ¾Ë·ÁÁ® ÀÖÁö ¾Ê´Ù. ÀÛ¿ëÁ¡Àº ÁßÃ߽Űæ°è¶ó°í ¿©°ÜÁö°í ÀÖ´Ù. ¶ÇÇÑ ¿¡Å׸£´Â °­ÇÑ ±ÙÀ°ÀÌ¿ÏÀÛ¿ëÀ» Áö³æ´Âµ¥, À̰ÍÀº ¿¡Å׸£°¡ ÁßÃ߽Űæ°è ¹× ½Å°æ£­±ÙÀ° Á¢ÇպΠµîÀÇ ¸»ÃÊ ºÎÀ§¿¡ ÀÛ¿ëÇϴ °á°úÀÌ´Ù. ½ÉÀå¿¡ÀÇ µ¶¼ºÀº Àû°í È£ÈíÀ» ÃËÁøÇϸç ÁßÃ߽Űæ°è¸¦ ÅëÇØ ±¸¿ªÀ̳ª ±¸Å並 ÃÊ·¡ÇÑ´Ù. ¶ÇÇÑ ÄáÆÏÀÇ Ç÷°üÀ» ¼öÃà½ÃŰ¹Ç·Î ¼Òº¯·®ÀÌ °¨¼ÒÇÑ´Ù. °£¿¡¼­ÀÇ µ¶¼ºÀº ³·Áö¸¸ °£±â´ÉÀ» ¾ïÁ¦Çϴ ÀÛ¿ëÀÌ ÀÖ´Ù. Ç÷¾×ÀÇ ÀÀ°í¸¦ ÀúÇØÇϴ ÀÛ¿ëÀº ¾ø´Ù. Ã¼³»¿¡ Èí¼öµÈ ¿¡Å׸£ÀÇ 90% ÀÌ»óÀº ´ë»çµÇÁö ¾ÊÀº Ã¤ È£±â·Î ¹è¼³µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ether
    ¿¡Å׸£
  • ether anesthesia
    ¿¡Å׸£¸¶Ãë
  • ether centrifugal sedimentation method
    ¿¡Å׸£¿ø½ÉħÀü¹ý
  • antimicrobial susceptibility
    Ç×±ÕÁ¦°¨¼ö¼º
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º°Ë»ç
  • dynamic susceptibility contrast technique
    ¿ªµ¿ÀÚÈ­À²´ëÁ¶±â¹ý
  • disease susceptibility
    Áúº´°¨¼ö¼º
  • genetic susceptibility
    À¯ÀüÀû°¨¼ö¼º
  • hypnotic susceptibility
    Ãָ鰨¼ö¼º
  • host susceptibility
    ¼÷ÁÖ°¨¼ö¼º
  • magnetic susceptibility
    ÀڱⰨ¼öÀ², ÀÚÈ­À², ´ëÀÚÀ²
  • magnetic susceptibility artifact
    ÀÚÈ­À²Àΰø¹°
  • magnetic susceptibility gradient
    ÀÚ±âÈ­À²±â¿ï±â
  • susceptibility
    °¨¼ö¼º
  • susceptibility gradient
    °¨¼ö¼º±â¿ï±â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ether
    ¿¡Å׸£
  • susceptibility
    °¨¼ö¼º
  • antimicrobial susceptibility
    Ç×±ÕÁ¦°¨¼ö¼º
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ether anesthesia
    ¿¡Å׸£¸¶Ãë
  • ether
    ¿¡Å׸£
  • ether centrifugal sedimentation method
    ¿¡Å׸£¿ø½ÉħÀü¹ý
  • formalin-ether sedimentation
    Æ÷¸£¸»¸°¿¡Å׸£Ä§Àü¹ý
  • antimicrobial susceptibility
    Ç×±ÕÁ¦°¨¼ö¼º
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè
  • magnetic susceptibility artifact
    ÀÚ±âÈ­À²Àΰø¹°
  • colorimetric caries susceptibility test
    ¿ì½Ä°¨¼ö¼ººñ»ö½ÃÇè
  • disease susceptibility
    Áúº´°¨¼ö¼º
  • dynamic susceptibility contrast technique
    ¿ªµ¿ÀÚÈ­À²´ëÁ¶±â¹ý
  • susceptibility distortion
    ÀÚÈ­À²¿Ö°î, °¨¼ö¼º¿Ö°î
  • magnetic susceptibility proton relaxation enhancement
    ÀÚ±âÈ­À²¾ç¼ºÀÚÀÌ¿ÏÁõ°­
  • genetic susceptibility
    À¯ÀüÀÚ°¨¼ö¼º, À¯ÀüÀû°¨¼ö¼º
  • magnetic susceptibility gradient
    ÀÚ±âÈ­À²±â¿ï±â
  • susceptibility gradient
    °¨¼ö¼º±â¿ï±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • petroleum ether
    ¼®À¯¿¡Å׸£.
  • phenyl ether
    Æä´Ò¿¡Å׸£.
  • antifungal susceptibility testing
    Ç×Áø±Õ°¨¼ö¼º½ÃÇè
  • antimicrobial susceptibility
    Ç×±ÕÁ¦°¨¼ö¼º
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè
  • antimicrobial susceptibility testing
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè¹ý
  • genetic susceptibility
    À¯ÀüÀû °¨¼ö¼º
  • genetic susceptibility
    À¯ÀüÀÚ°¨¼ö¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ether susceptibility
    ¿¡Å׸£°¨¼ö¼º (¿ÜÇǺ¸À¯¹ÙÀÌ·¯½ºÀÇ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bis(choromethyl) ether
    È­¿°¸ð¾ç ¸ð¹Ý(ûýæûÙ¼åÆÙ½Úè)
  • chloromethyl methyl ether
    Ŭ·Î·Î¸ÞÅÚ¿¡Å׸£
  • diethyl ether
    µð¿¡Æ¿¿¡Å׸£.
  • divinyl ether
    µðºñ´Ò ¿¡Å׸£.
  • ether
    ¿¡Å׸£
  • ether
    ÀÌÅÍ.
  • ether
    ¿¡Å׸£, ¿¡ÅÚ.
  • ether anesthesia
    ¿¡Å׸£¸¶Ãë¹ý.
  • ether bronchitis
    ¿¡Å׸£±â°üÁö¿°.
  • mitigated ether
    ¿ÏÈ­(èÐûú)¿¡Å׸£.
  • mitigated ether
    ¿ÏÈ­(èÐûú)¿¡Å׸£ ¡ìŬ·Î·ÎÆ÷¸§È¥ÇÕ¡í.
  • petroleum ether
    ¼®À¯¿¡Å׸£.
  • phenyl ether
    Æä´Ò¿¡Å׸£.
  • trifluoroethyl vinyl ether
    Æ®¸®Ç÷ç¿À·Î¿¡Æ¿ºñ´Ò¿¡Å׸£.
  • antifungal susceptibility testing
    Ç×Áø±Õ°¨¼ö¼º½ÃÇè
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • formalin-ether sedimentation technique
    Æ÷¸£¸»¸°¿¡Å׸£Ä§Àü¹ý
  • host susceptibility
    ¼÷ÁÖ°¨¼ö¼º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • magnetic susceptibility
    ÀÚÈ­À²(í¸ûùëÒ)
  • ether
    ÀÌÅÍ
  • thiol ether
    ŸÀ̿à ÀÌÅÍ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ether
    ¿¡Å׸£, ¿¡ÅÚ
  • dynamic susceptibility contrast technique
    ¿ªµ¿ÀÚÈ­À²´ëÁ¶±â¹ý
  • gradient echo technique magnetic susceptibility proton relaxation enhancement
    °æ»ç¿¡ÄÚ¹ý±âÈ­À²¼ºÀÚÀÌ¿ÏÁõ°­
  • magnetic susceptibility
    ÀÚ±âÈ­À²
  • magnetic susceptibility artefact
    ÀÚ±âÈ­À²Àΰø¹°
  • magnetic susceptibility gradient
    ÀÚ±âÈ­À²°æ»ç
  • magnetic susceptibility variation
    ÀÚ±âÈ­À²º¯ÀÌ
  • mass susceptibility
    Áú·®¹Î°¨µµ
  • molar susceptibility
    ¸ô´ç·®°¨¼ö¼º
  • paramagnetic high susceptibility
    »óÀÚ¼º°íÀÚÈ­À²
  • paramagnetic susceptibility effect
    »óÀÚ¼ºÀÚ±âÈ­È¿°ú
  • susceptibility
    °¨¼ö¼º, ÀÌȯ¼º, ÀÚÈ­À²
  • susceptibility artifact
    ÀÚÈ­À²Àΰø¹°, °¨¼ö¼ºÀΰøÀ½¿µ
  • susceptibility distortions
    ÀÚÈ­À²¿Ö°î
  • susceptibility gradient
    ÀÚÈ­À²°æ»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MSS Marshall-Smith syndrome; massage; Medical Superintendents' Society; Medicare Statistical System; men...
CB3S Coxsackie B3 virus susceptibility
cm magnetic susceptibility
cs electric susceptibility
CVS cardiovascular surgery; cardiovascular system; challenge virus strain; chorionic villi sampling; cle...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PEEK Poly(ether ether ketone
DSC Dynamic susceptibility contrast
HGSHS:A Harvard Group Scale of Hypnotic Susceptibility, Form A
MHS Malignant hyperthermia susceptibility
S R)/susceptibility
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • aether : µ¿ÀǾî=ether.

    aethiops

    ¼®È¸, ¼®Åº
  • chloromethyl ether
    Ŭ·Î·Î¸ÞÆ¿ ¿¡Å׸£
  • ether
    ÀÌÅÍ, ¿¡Å׸£
    1. ƯÀ¯ÀÇ ³¿»õ¸¦ °®´Â ¹«»öÀÇ ÀÎÈ­¼º ¾×ü. ¾ËÄڿÿ¡ ÁøÇÑ È²»êÀ» °¡ÇÏ°í °¡¿­Çؼ­ ¸¸µç´Ù. ºÐ¼®¿ë ½Ã¾à, ¿ëÁ¦, ¸¶ÃëÁ¦ µîÀ¸·Î »ç¿ëµÈ´Ù. 2. Àü½Å ¸¶ÃëÁ¦·Î °¡Àå ¸¹ÀÌ »ç¿ëµÈ´Ù. »õ·Î¿î ÈíÀÔ ¸¶ÃëÁ¦ÀÇ °³¹ß·Î ÇöÀç´Â °ÅÀÇ »ç¿ëÇÏÁö ¾Ê´Ù. ¹«»öÀÇ ÀڱؼºÀÎ ³¿»õ¸¦ Áö´Ñ Èֹ߼ºÀÌ °­ÇÑ ¾×ü. ºñÁßÀº 25¡É¿¡¼­ 0.714ÀÌ°í ºñÁ¡Àº 34.6¡ÉÀ̸ç ÀÎÈ­¼ºÀÎ °­ÇØ °ø±â, ¾Æ»êÈ­ Áú¼Ò ¹× »ê¼ÒÀÇ È¥ÇÕ¹°Àº Æø¹ßÇÑ´Ù. ½ÇÁ¦ ¸¶Ãë¿ë ether´Â »êÈ­¸¦ ¹æÁöÇϱâ À§ÇÏ¿© 1.8%ÀÇ ¿¡Å¸³î°ú 0.5%ÀÇ ¹°À» ÇÔÀ¯ÇÏ¸ç µ¿À¸·Î µµ±ÝµÈ ±Ý¼Ó ¿ë±â¿¡ ¹ÐÆóµÇ¾î °ø±ÞÇÑ´Ù. ¸¶Ãë À¯µµ°¡ ´À¸®°í ºÒÄèÇϱ⠶§¹®¿¡ Á¤¸Æ ¸¶ÃëÁ¦·Î½á ¸¶Ãë À¯µµ¸¦ Çϸç ȸº¹µµ ´À¸®´Ù. ¿À½É, ±¸Åä, °æ·Ã, ¹ß¿­, Å»¼ö, »êÇ÷Áõ µîÀÇ ºÎÀÛ¿ëµµ ÀÏÀ¸Å³ ¼ö ÀÖ´Ù.
  • ether reflex
    ÀÌÅÍ ¹Ý»ç
    ÀÌÅÍ ¹× ±âŸ ƯÁ¤ ¹°ÁúÀ» ½ÊÀÌÁöÀå¿¡ ÁÖÀÔÇßÀ» ¶§ ÀϾ´Â µ¹¹ßÀûÀÎ ´ë·®ÀÇ ½ÊÀÌÁöÀå ºÐºñ.
  • antimicrobial susceptibility
    Ç×±ÕÁ¦ °¨¼ö¼º, Ç×±Õ °¨¼ö¼º
  • caries susceptibility test
    Ä¡¾Æ ¿ì½Ä °¨¼ö¼º ½ÃÇè
  • magnetic susceptibility artifact
    ÀÚ±âÈ­À² Àΰø¹°
  • magnetic susceptibility variation
    ÀÚ±âÈ­À² º¯ÀÌ
  • mass susceptibility
    Áú·® ¹Î°¨µµ
  • paramagnetic high susceptibility
    »óÀÚ¼º °íÀÚÈ­À²
  • paramagnetic susceptibility effect
    »óÀÚ¼º ÀÚ±âÈ­ È¿°ú
  • susceptibility test
    °¨¼ö¼º ½ÃÇè, °¨¼ö¼º Å×½ºÆ®, °¨¼ö¼º °Ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
BRCA1 breast cancer susceptibility gene This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer.
(12 Dec 1998)
breast cancer susceptibility genes Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered.
(12 Dec 1998)
cancer, breast, susceptibility genes Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered.
(12 Dec 1998)
cancer susceptibility gene tumour suppressor gene
genes, breast cancer susceptibility Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. Howeverm, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. See related entries to: BRCA1; BRCA2; Breast cancer, familial.
(12 Dec 1998)
colourimetric caries susceptibility test A colourimetric test for determining dental caries activity or susceptibility based on the rate of acid production by acidogenic oral microorganisms (e.g., lactobacillus) in a glucose medium, using bromcresol green as the indicator, and producing a colour change from green to yellow.
Synonym: colourimetric caries susceptibility test.
(05 Mar 2000)
susceptibility Origin: Cf. F. Susceptibilite.
1. The state or quality of being susceptible; the capability of receiving impressions, or of being affected.
2. Specifically, capacity for deep feeling or emotional excitement; sensibility, in its broadest acceptation; impressibility; sensitiveness.
<physics> Magnetic susceptibility, the intensity of magnetization of a body placed in a uniform megnetic field of unit strength.
Synonym: Capability, sensibility, feeling, emotion.
Source: Websters Dictionary
(01 Mar 1998)
susceptibility testing The determination of the ability of an antibiotic to kill or inhibit the growth of bacteria.
(05 Mar 2000)
disease susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.
(12 Dec 1998)
anaesthetic ether General designation for many ether's.
(05 Mar 2000)
bis(chloromethyl) ether <chemical> Sym-dlchloromethyl ether. A substance that is an irritant to the eyes and respiratory tract and may be carcinogenic.
Pharmacological action: carcinogens, irritants.
Chemical name: Methane, oxybis(chloro-
(12 Dec 1998)
boldine dimethyl ether <chemistry> An alkaloid obtained from the plant Glaucium, as a bitter, white, crystalline substance.
Source: Websters Dictionary
(01 Mar 1998)
vinyl ether O(CH==CH2)2;a volatile liquid, the vapor of which produces rapid induction of general anaesthesia; prolonged administration is associated with adverse side effects on the liver and central nervous system; an obsolete agent.
Synonym: vinyl ether.
(05 Mar 2000)
guaiacol glyceryl ether <chemical> 3-(2-methoxyphenoxy)-1,2-propanediol. An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Pharmacological action: expectorants.
Chemical name: 1,2-Propanediol, 3-(2-methoxyphenoxy)-
(12 Dec 1998)
guaiacylglycerol beta-O-4-guaiacyl ether dehydrogenase <enzyme> Nad+ required; forms the corresponding ketone at the alpha carbon of the glycerol side chain
Registry number: EC 1.1.1.-
Synonym: gge dehydrogenase
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • susceptibility
    °¨¼ö¼º
  • susceptibility
    °¨¼ö¼º(to);°¨Á¤
  • crown ether
    Å©¶ó¿î ¿¡Å׸£
  • ether
    ¿¡Å׸£;Á¤±â;ÇÏ´Ã
  • petroleum ether
    ¼®À¯ ¿¡Å׸£
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á